Delivery Order SPE2DB24D9238-SPE2DB25FDQXE
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 by the Defense Logistics Agency (DLA) on August 18, 2025. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials, a long-acting local anesthetic commonly used in surgical and post-operative pain management. This firm fixed-price delivery order, with an ultimate completion date of September 9,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine local anesthetic commonly used in surgical and post-operative pain management. The delivery order is scheduled for completion by June 24, 2025, with the place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,770.20 by the Defense Logistics Agency (DLA) on September 5, 2025. The delivery order is for 4,569,416,460 units of EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine product used for post-operative pain management. The contract carries an ultimate completion date of September 26, 2025, and includes no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 12, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical and pain management applications. The delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,185.32 by the Defense Logistics Agency (DLA) on September 12, 2025. The order covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine product used for local anesthesia and pain management in surgical and medical applications. This is a firm fixed-price delivery order with no set-aside designation, reflecting the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on September 3, 2025. The contract covers the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical settings, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and will be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $52,649.48 by the Defense Logistics Agency on September 5, 2025. The contract calls for the delivery of Exparel 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic commonly used for surgical pain management. The delivery order is not set-aside designated and carries an ultimate completion date of September 26,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQXEDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 22, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine product used for post-operative pain management. The contract carries no set-aside designation and requires ultimate completion by August 12, 2025, with performance to be executed at the contractor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts for specialty pharmaceuticals, biologics, and medical consumables distributed to Department of Defense healthcare sites nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 7/22/25 |